Asset Advisors Investment Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Asset Advisors Investment Management’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.7M	Sell	86,271 -18,271	-17%	-$2.72M	1.26%	24
2026 Q1	$15.3M	Buy	104,542 +5,809	+6%	+$896K	1.46%	24
2025 Q4	$15.3M	Buy	98,733 +5,241	+6%	+$785K	1.41%	24
2025 Q3	$13M	Sell	93,492 -6,052	-6%	-$819K	1.23%	28
2025 Q2	$13.4M	Sell	99,544 -4,538	-4%	-$613K	1.33%	24
2025 Q1	$15.2M	Buy	104,082 +3,478	+3%	+$505K	1.6%	21
2024 Q4	$13.8M	Buy	100,604 +5,480	+6%	+$802K	1.45%	22
2024 Q3	$14.7M	Buy	95,124 +9,177	+11%	+$1.39M	1.52%	22
2024 Q2	$12.5M	Buy	85,947 +26,948	+46%	+$3.87M	1.36%	24
2024 Q1	$8.72M	Buy	58,999 +13,903	+31%	+$1.99M	0.98%	31
2023 Q4	$6.15M	Buy	45,096 +2,280	+5%	+$297K	0.75%	34
2023 Q3	$5.51M	Sell	42,816 -515	-1%	-$68.4K	0.74%	35
2023 Q2	$5.75M	Sell	43,331 -754	-2%	-$99.4K	0.73%	35
2023 Q1	$5.71M	Buy	44,085 +300	+0.7%	+$39.2K	0.75%	35
2022 Q4	$5.95M	Buy	43,785 +100	+0.2%	+$13.3K	0.78%	36
2022 Q3	$5.29M	Buy	43,685 +1,180	+3%	+$152K	0.75%	37
2022 Q2	$5.45M	Buy	42,505 +1,190	+3%	+$156K	0.74%	36
2022 Q1	$5.66M	Buy	41,315 +2,950	+8%	+$391K	0.63%	40
2021 Q4	$5.41M	Buy	38,365 +5,070	+15%	+$673K	0.54%	43
2021 Q3	$4.24M	Buy	33,295 +1,375	+4%	+$182K	0.47%	47
2021 Q2	$4.02M	Buy	31,920 +4,075	+15%	+$499K	0.44%	50
2021 Q1	$3.28M	Buy	27,845 +1,560	+6%	+$180K	0.38%	52
2020 Q4	$2.98M	Buy	26,285 +1,000	+4%	+$109K	0.39%	48
2020 Q3	$2.67M	Sell	25,285 -2,625	-9%	-$276K	0.4%	46
2020 Q2	$2.79M	Buy	27,910 +4,815	+21%	+$475K	0.45%	44
2020 Q1	$2.05M	Buy	23,095 +14,700	+175%	+$1.43M	0.38%	48
2019 Q4	$865K	Buy	+8,395	New	+$807K	0.13%	71

Other funds holding XLV

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

RIG

RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return

Greenwood Gearhart Fayetteville, Arkansas $2.15B AUM 25.78% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Asset Advisors Investment Management's XLV Position: Q2 2026 in Review

Asset Advisors Investment Management reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 17% in Q2 2026, selling an estimated $2.72M and leaving 86,271 shares worth $13.7M. The position accounts for 1.26% of the portfolio, ranked #24.

Asset Advisors Investment Management first reported a position in XLV in Q4 2019 and has held it in 27 quarters since. The position peaked at $15.3M in Q1 2026. 820 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Asset Advisors Investment Management held 86,271 shares of State Street Health Care Select Sector SPDR ETF worth $13.7M as of Q2 2026.
Asset Advisors Investment Management sold 18,271 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $2.72M.
State Street Health Care Select Sector SPDR ETF made up 1.26% of Asset Advisors Investment Management's portfolio in Q2 2026, its #24 holding.
Asset Advisors Investment Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2019 and has held it in 27 quarters since.
Asset Advisors Investment Management's State Street Health Care Select Sector SPDR ETF position peaked at $15.3M in Q1 2026.
820 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Asset Advisors Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.